INTERNATIONAL PATENT: CEMM - FORSCHUNGSZENTRUM FUR MOLEKULARE MEDIZIN GMBH FILES APPLICATION FOR "INHIBITORS OF SMNDC1 AND THEIR THERAPEUTIC USE"

GENEVA, Jan. 27 -- CEMM - FORSCHUNGSZENTRUM FUR MOLEKULARE MEDIZIN GMBH (Lazarettgasse 14 / AKH BT 25.31090 Wien) filed a patent application (PCT/EP2024/070646) for "INHIBITORS OF SMNDC1 AND THEIR THERAPEUTIC USE" on Jul 19, 2024. With publication no. WO/2025/017207, the details related to the patent application was published on Jan 23, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ENDERS, Lennart (CeMM - Forschungszentrum fur Molekulare Medizin GmbHLazarettgasse 14 / AKH BT 25.31090 Wien), SIKLOS, Marton (CeMM - Forschungszentrum fur Molekulare Medizin GmbHLazarettgasse 14 / AKH BT 25.310...